WELL Health Technologies Corp
TSX:WELL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
WELL Health Technologies Corp
TSX:WELL
|
CA |
|
Kuang-Chi Technologies Co Ltd
SZSE:002625
|
CN |
|
SS&C Technologies Holdings Inc
NASDAQ:SSNC
|
US |
|
Eastman Kodak Co
NYSE:KODK
|
US |
|
C
|
Cultural Investment Holdings Co Ltd
SSE:600715
|
CN |
|
W
|
Wizz Air Holdings PLC
OTC:WZZZY
|
CH |
|
Bajaj Consumer Care Ltd
NSE:BAJAJCON
|
IN |
|
Yes Bank Ltd
NSE:YESBANK
|
IN |
|
H
|
Heineken NV
SWB:HNK1
|
NL |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
Imperial Metals Corp
TSX:III
|
CA |
WELL Health Technologies Corp
In the digital age of healthcare, WELL Health Technologies Corp. emerges as a quiet but formidable innovator, weaving technology and wellness into a comprehensive ecosystem. Founded in 2010, the company has grown from its Canadian roots to become a major player in the health-tech landscape, driven by a mission to modernize and improve healthcare access. WELL Health operates primarily within the electronic medical records (EMR) sector, offering physicians and clinics a seamless transition from traditional paper-based systems to robust digital platforms. With a series of strategic acquisitions, WELL has expanded its portfolio to include telehealth services, medical services, and digital health applications, effectively building an integrated network that caters to both healthcare providers and patients. This blend of services positions WELL Health as a pioneer in overhauling how healthcare systems interact with technology, thereby laying the groundwork for a more efficient, patient-centric approach.
WELL Health Technologies generates revenue through a multifaceted business model that hinges on its diverse array of service lines. The company earns by licensing its EMR software to clinics and practitioners, ensuring a steady stream of recurring revenue. Additionally, its telehealth services, which provide virtual healthcare consultations, have gained traction, especially amid the increased demand for remote healthcare solutions. The acquisition strategy further enriches WELL’s revenue sources, allowing it to tap into various niche markets such as cybersecurity for healthcare data and provider billing services. These services not only diversify WELL Health’s income streams but also enhance the value proposition to its users by offering a one-stop shop for healthcare solutions. Through a carefully orchestrated expansion, WELL Health Technologies continues to redefine the synergy between health and technology, anchoring itself firmly as a vital conduit in the ever-evolving healthcare domain.
In the digital age of healthcare, WELL Health Technologies Corp. emerges as a quiet but formidable innovator, weaving technology and wellness into a comprehensive ecosystem. Founded in 2010, the company has grown from its Canadian roots to become a major player in the health-tech landscape, driven by a mission to modernize and improve healthcare access. WELL Health operates primarily within the electronic medical records (EMR) sector, offering physicians and clinics a seamless transition from traditional paper-based systems to robust digital platforms. With a series of strategic acquisitions, WELL has expanded its portfolio to include telehealth services, medical services, and digital health applications, effectively building an integrated network that caters to both healthcare providers and patients. This blend of services positions WELL Health as a pioneer in overhauling how healthcare systems interact with technology, thereby laying the groundwork for a more efficient, patient-centric approach.
WELL Health Technologies generates revenue through a multifaceted business model that hinges on its diverse array of service lines. The company earns by licensing its EMR software to clinics and practitioners, ensuring a steady stream of recurring revenue. Additionally, its telehealth services, which provide virtual healthcare consultations, have gained traction, especially amid the increased demand for remote healthcare solutions. The acquisition strategy further enriches WELL’s revenue sources, allowing it to tap into various niche markets such as cybersecurity for healthcare data and provider billing services. These services not only diversify WELL Health’s income streams but also enhance the value proposition to its users by offering a one-stop shop for healthcare solutions. Through a carefully orchestrated expansion, WELL Health Technologies continues to redefine the synergy between health and technology, anchoring itself firmly as a vital conduit in the ever-evolving healthcare domain.
Results: WELL reported 2025 revenue of $1.4 billion, adjusted EBITDA of $203.7 million (14.5% margin) and adjusted net income of $126.5 million or $0.50 per share.
Normalization: On a normalized basis (excluding Circle Medical deferred revenue and CRH cyber impacts) 2025 revenue was $1.35 billion and adjusted EBITDA was $148.6 million.
Operations: WELL now operates 252 clinics in Canada, delivered 4.3 million Canadian patient visits in 2025, and has over 4,600 providers across its network.
Technology momentum: WELLSTAR ARR reached $72.6 million and HEALWELL contributed $112.9 million of revenue in 2025; HEALWELL Q4 revenue was $32.2 million and Q4 adjusted EBITDA was $1.1 million.
Capital & cash: Cash and cash equivalents were $133.8 million; outstanding credit lines were approximately CAD 377 million and the company expanded its senior secured facility to CAD 400 million with a $100 million accordion and maturity to January 2030.
M&A pipeline: Q4 added 25 clinics ($45.6 million in annual revenue); full-year clinic M&A added $113 million in clinical revenue; ~$260 million of clinic revenue is under LOI or advanced stage.
U.S. assets: WELL is in active strategic sale processes for Wisp, Circle Medical and CRH; an agreement in principle was reached with the DOJ for Circle Medical and the company re-recognized USD 13 million of previously derecognized CRH revenue.
Guidance: 2026 revenue guidance of $1.55 billion to $1.65 billion and adjusted EBITDA guidance of $175 million to $185 million (includes $17.6 million Circle Medical deferred revenue expected to be recognized in 2026).
